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"Application"	means	 the	 application	 by	 the	 Lynx	 Trust	 [to	 SNH]	 for	 a	 licence	 pursuant	 to	
section	16	of	the	WCA	to	release	Lynx	into	the	UK	on	a	trial	basis.		
	
"Application Document" means the text of the application only and does not include the 





"IUCN	 Guidelines"	 means	 the	 Guidelines	 for	 reintroductions	 and	 Other	 Conservation	
Translocations	(2013),	available	online	at	www.iuchsscrsg.org.	
	
“IUCN	 Guidelines	 for	 DRA”	 means	 The	 IUCN/OIE	 Guidelines	 for	 Wildlife	 Disease	 Risk	
Assessment	(2014)	available	online	at		
	
"Key Themes" means the key themes which arise as a result of the Consultations cumulatively 
as set out in section [] of the National Public Survey, section [] of the National Consultation 












"NE" means Natural England.  
"PALC" means the pre-application local stakeholder and community consultation process as 













"Project Plan" means [●]. 
"Release Pen" means []. 
"SNH"	means	Scottish	Natural	Heritage.	
	
"SNH Code" Translocations & Best Practice Guidelines for Conservation Translocations in 
















































The	 Lynx	 Trust	 (“Lynx	 Trust”)	 has	 put	 together	 a	multidisciplinary	 team	 (consisting	 of	 its	
Directors,	 volunteers,	 Advisers	 (“Advisers”)	 and	 Partners	 (“Partners”))	 which	 comprises	
academic	 ecologists,	 ecological	 consultants,	 veterinarians,	 public	 consultation	 experts,	
economic	consultants,	socio-economic	consultants,	forestry	specialists,	public	policy	experts,	
PR	experts,	media	advisers	and	lawyers.	All	team	members	are	highly	qualified	experts	in	their	
















Trial	 during	 which	 [NE/UK	 Gov/SNH/Scot	 Gov]	 has	 not	 made	 a	 final	 decision	 on	 Lynx	




























Trial.	 	 Translocation	 affects	 host-pathogen	 communities	 in	 the	 donor	 and	 release	
environments.	The	primary	aim	of	the	DRA		is	to	proactively	minimize	the	likelihood	of	disease	
in	 the	 Trial	 Animals,	 other	wildlife,	 domesticated	 species	 and	 humans,	 by	 identifying	 and	

























translocation	 of	 species	 from	 a	 donor	 to	 a	 destination	 environment(4).	 Historically,	 DRA	
frameworks	were	applied	ad?hoc	to	situations	involving	wildlife,	often	without	a	consistent	
approach.	 Therefore,	 the	 IUCN	 Guidelines	 for	 DRA
12





of	 risks	 associated	with	 the	hazards,	 the	management	 of	 risks	 and	 the	 communication	of	
outcomes(4).	 The	 communication	 of	 risk	 to	 a	 wide	 range	 of	 stakeholders	 (e.g.	 statutory	
authorities,	 scientists,	 livestock	 farmers,	 conservation	 NGOs)	 will	 enable	 them	 to	 make	



























































[Quantitative	 disease	 risk	 assessments	 for	 the	 translocation	 of	 wild	 animals	 are	 often	
constrained	 by	 insufficient	 data	 relating	 to	 the	 prevalence,	 distribution,	 transmission	 and	
pathogenicity	 of	 aetiological	 agents	 within	 the	 population.	 This	 DRA	 uses	 a	 structured	
qualitative	approach	to	account	for	the	lack	of	precise	quantitative	data	and	to	incorporate	
expert	scientific	opinion	as	well	as	information	from	the	published	literature.	In	qualitative	
risk	assessments	 the	 likelihood	of	 the	outcome,	or	 the	magnitude	of	 the	consequences,	 is	
expressed	in	pre-defined	terms	such	as	‘high’,	‘medium’	or	‘low’.	
	
The	 authors	 used	 the	 method	 described	 by	 Sainsbury	 and	 Vaughan-Higgins	 (5)	 which	 is	
aligned	with	 the	 IUCN	Guidelines	 for	DRA.	 Infectious	and	non-infectious	causes	of	disease	
were	considered	to	be	a	hazard	if	they	had	crossed	an	ecological	or	geographic	barrier	and	
were	novel	to	the	host.	We	defined	a	geographic	barrier	as	a	natural	or	man-made	formation	
or	 body	 of	 water	 that	 constrains	 the	 physical	 movement	 of	 pathogens	 or	 their	 host.	 An	





















unless	 they	 occurred	 as	 novel	 subtypes,	 were	 notifiable	 to	 the	 local	 authority	 in	 the	
destination	environment	or	constituted	a	significant	population	and/or	zoonotic	risk.	Risk	was	













related	 stress	 could	 result	 in	 host-immunodeficiency	 and	 disease.	 Infectious	 and	 non-































home	 range.	 The	 release	 of	 single	 sex	 individuals	 would	 result	 in	 an	 increased	 rate	 and	
distance	 of	 dispersal	 as	 animals	 search	 for	 breeding	 opportunities.	 Increased	 levels	 of	































the	 country	 (8).	 The	most	 recent	 census	 between	 2009	 and	 2011	 estimated	 the	 national	
population	to	be	between	1400-1900	individuals	(8).		
	
The	 Team	 is	 currently	 in	 discussions	 with	 a	 number	 of	 potential	 partner	 organizations	
including	 the	 Swedish	National	 Veterinary	 Institute	 (SVA)	 and	 the	 Swedish	 Environmental	
Protection	Agency	(EPA).	These	conversations	will	build	reliable	partnerships,	ensuring	proper	
procedures	and	safeguards	are	observed	in	the	identification	of	potential	source	populations.	































































The	 Team	 plans	 to	 draw	 on	 the	 expertise	 of	 professor	 Henrik	 Andren	 from	 the	 Swedish	















































































Further	 research	 relating	 to	 the	 Colorado	 Lynx	 reintroduction	 program	 (13)	 revealed	 that	
average	monthly	mortality	rates	during	the	first	year	decreased	with	time	in	captivity	from	
0.205	(95%	CI = 0.069,	0.475)	for	Lynx	having	spent	up	to	7	days	in	captivity	to	0.028	(95%	
CI = 0.012,	 0.064)	 for	 lynx	 spending	 >45	 days	 in	 captivity	 before	 release.	 No	 significant	
additional	increases	in	survival	rates	were	found	beyond	5-6	weeks	post-release	(13).	
	

























































































assigned	 5	 Infections	 (rabies	 virus,	 Fransicella	 tularensis,	 Sarcoptes	 scabei,	 tick-borne	
















































The	 assessment	 of	 disease	 risk	 incorporates	 the	 likelihood	 of	 Lynx	 carrying	 and	 releasing	
Infections	at	the	recipient	site	(release	assessment),	the	probability	of	disease	transmission	
to	Lynx	and	sympatric,	resident	species	at	the	release	site	(wildlife,	domestic	livestock,	pets	





















































































































































colour-coded	hazards	with	 the	potential	 for	 severe	 impacts	at	an	 individual	or	population	










demeanor,	 appetite	 and	 thirst,	 mobility	 and	 behaviour	 of	 the	 Lynx.	 Furthermore,	
observations	 will	 identify	 hazard	 specific	 symptoms	 such	 as	 pruritis	 (Sarcoptes	 scabei,	
Otodectes	cynotis)	and	evidence	of	stress	induced	trauma	to	distal	extremities.	The	detection	





collect	 biological	 samples	 for	 diagnostic	 screening,	 apply	 prophylactic	 and	 therapeutic	
treatments	and	take	morphometric	measurements.	To	mitigate	 the	risks	of	morbidity	and	


























Prophylactic	 interventions	 administered	 prior	 to	 export	 comprise	 vaccinations	 and	


























diet	 to	which	 the	 Lynx	were	 accustomed	 in	 the	 source	 environment.	 Veterinary	 staff	will	
conduct	 meat	 inspections	 prior	 to	 feeding	 wild	 prey	 to	 identify	 lesions	 associated	 with	
infectious	disease	such	as	Mycobacterium	bovis	and	Sarcoptes	scabei.	The	provision	of	fresh	
or	 frozen	 carcasses	 will	 help	 to	 prevent	 bacterial	 contamination	 with	 pathogens	 such	 as	
















Prior	 to	 release	 a	 second	 anaesthetic	 will	 be	 administered,	 to	 enable	 a	 comprehensive	
physical	 examination	 and	 weight	 check	 to	 be	 carried	 out	 and	 to	 fit	 individual	 Lynx	 with	








‘Illegal	 Persecution’	 in	 Appendix	 2.	 It	 is	 imperative	 that	 the	 community	 engagement	
programme	implemented	prior	to	the	licensing	stage	is	continued	in	the	release	zone	post-
licensing.	This	will	help	to	inform	the	community	of	the	mitigation	measures	that	have	been	









Lynx	mortality	events	will	be	 investigated	at	all	 stages	of	 the	 translocation	pathway	by	Dr	
Julian	 Chantrey	 from	 the	 University	 of	 Liverpool	 Veterinary	 Institute	 according	 to	 the	
necropsy	 protocol	 outlined	 in	 Appendix	 3.	 Diagnostic	 tests	 will	 include	 gross	 necropsy,	
histopathology	 and	 toxicology	 screens	 and	 the	 cause	 of	 death	 will	 inform	 the	mitigation	




























including	 the	 Lynx	 Trust	 Team	 as	 well	 as	 the	 statutory	 authorities	 (NE,	 SNH,APHA)	 and	






drawn	on	a	 reference	 library	of	published	articles	 relating	 in	some	part	 to	 feline	diseases.	
























from	disease	 free	areas	 (Sweden	 for	 rabies);	 treating	all	 imported	 lynx	with	anthelmintics	
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by	 the	poisoner.	Lynx	could	be	exposed	to	 illegal	poisons	such	as	carbofuran	as	 they	have	been	documented	to	
consume	carrion	if	live	prey	is	scarce	through	the	winter	months	(7).	
	
Many	 studies	 have	 analyzed	 the	 spatial	 distribution	 of	 illegal	 persecution	 incidents	 and	 have	 documented	 an	
association	with	open	moorland	areas	managed	for	high	value	driven	red	grouse	shooting	(5).	The	reintroduced	Lynx	


















































































































































































































Sex:	______________		 	 	 	 Weight:	_______________		
	
Date	of	birth	(if	known)	:	______________		 Age:	_______________		
	
Where	found	(including	GPS	location	if	possible):___________________________________		
	
Environmental	conditions:______________________________________________________		
	
Date	of	death:	__________________		
	
Date	of	necropsy:	______________		
	
Proven	breeder:	______________________________________________________________		
	
	
History	(include	clinical	signs	and	circumstances	of	death):		
	
_____________________________________________________________________		
	
_____________________________________________________________________				
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GROSS	NECROPSY	FINDINGS:		
Fill	in	details	of	gross	necropsy	findings	in	sections	below,	or	circle	one	of	NAD	(no	abnormality	
detected)	or	NE	(not	examined).		
	
It	is	extremely	valuable	if	you	can	take	digital	images	of	any	abnormalities	found		
	
General	condition:	(nutritional	condition,	physical	condition,	carcass	fresh	or	decomposed	etc).		
NAD/NE		
	
Skin:	(NB	in	the	case	of	a	neonate,	examine	the	umbilical	stump	and	surrounding	tissues)		
NAD/NE		
	
Musculoskeletal	system:	(bones,	joints,	muscles)		
NAD/NE		
	
Body	cavities:	(fat	stores,	abnormal	fluids)		
NAD/NE		
	
Lymphoreticular	system:	(spleen,	lymph	nodes,	lymphatics,	thymus)		
NAD/NE		
	
Respiratory	system:	(nasal	cavity,	larynx,	trachea,	lungs,	regional	LN's.	In	neonates	note	whether	
lungs	float	or	sink	in	formol	saline)		
	
Digestive	system:	(mouth,	teeth,	oesophagus,	stomach,	intestines,	liver,	pancreas,	mesenteric	
lymph	nodes.	In	the	case	of	a	neonate,	note	whether	milk	is	present	in	the	stomach)		
NAD/NE		
	
Cardiovascular	system:	(heart,	pericardium,	blood	vessels)		
NAD/NE		
	
Urinary	system:	(kidneys,	ureters,	urinary	bladder,	urethra)		
NAD/NE		
	
Reproductive	system:	(testes/ovaries,	uterus,	vagina,	penis,	prepuce,	accessory	glands,	mammary	
glands,	placenta)		
NAD/NE		
	
Endocrine	system:	(adrenals,	thyroid,	parathyroids,	pituitary)		
NAD/NE		
	
Nervous	system:	(brain,	spinal	cord,	peripheral	nerves)		
NAD/NE		
	
Sensory	organs:	(ears,	eyes)		
NAD/NE		
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LABORATORY	TESTS	&	DIAGNOSES:		
	
Laboratory	Tests:		
Give	details	of	all	specimens	submitted	for	bacteriology,	virology,	parasitology,	histopathology.		
	
Please	attach	reports	of	these	tests	to	the	completed	form.		
	
Bacteriology:	Report	attached:	Y/N		
	
Virology:	Report	attached:	Y/N		
	
Parasitology:	Report	attached:	Y/N		
	
Histopathology:	Report	attached:	Y/N		
	
Other:	(specify)	Report	attached:	Y/N		
	
Preliminary	diagnosis:		
FINAL	DIAGNOSIS:		
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TISSUES	FOR	STORAGE		
In	addition	to	specimens	submitted	for	diagnostic	pathology,	the	following	tissues	should	be	
preserved	in	10%	buffered	formal	saline	at	a	ratio	of	1	part	tissue	to	10	parts	formal	saline.	Sections	
should	be	no	thicker	than	1	cm.	Examples	of	all	lesions	should	also	be	included.	Tissues	should	be	
accurately	labelled	and	stored.		
	
Tissue	Area	Taken	(y/n)		
	
Adrenal	Entire	gland	with	transverse	cut	______		
	
Brain	Sliced	longitudinally	along	midline	______		
	
Heart	Entire	heart	after	opening	&	examining	atria,	______		
ventricles	and	valves	from	each	side		
	
Intestines	3cm	lengths	of	duodenum,	jejunum,	ileum,	______		
caecum	&	colon	Open	along	long	axis		
	
Kidney	Section	of	cortex,	medulla	&	pelvis	from	each	______		
	
Liver	2	sections	from	2	lobes	with	capsule	and	______		
gall	bladder		
	
Lung	Sections	from	several	lobes	including	a	______		
bronchus		
	
Lymph	nodes	Cervical,	anterior	mediastinal,	bronchial,	______		
mesenteric	and	lumbar	with	a	transverse	cut		
	
Pancreas	Samples	from	2	areas	______		
	
Peripheral	nerve	3cm	section	of	sciatic	nerve	______	
		
Skeletal	muscle	Cross-section	of	thigh	muscles	______		
	
Skin	3cm	length	of	full	thickness	abdominal	skin	_____		
	
Spleen	Cross	section	including	capsule	______		
	
Spinal	cord	Sections	from	cervical,	thoracic	&	lumbar	cord	______		
	
Stomach	Cardia,	antrum	and	pylorus	______		
	
Testis/ovary	Entire	with	transverse	cut	______		
	
Thyroid	Intact	including	parathyroids	______		
	
Urinary	bladder	Cross-section	______		
	
Uterus	Entire	with	longitudinal	cut	into	lumen	______	
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Appendix	4.		
	
Hazard	Identification	Spreadsheet	(see	supporting	excel	spreadsheet)	
		
	
	
	
